Raymond James Financial Services Advisors’s Ocugen OCGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-22,923
Closed -$13.2K 3465
2023
Q4
$13.2K Buy
22,923
+3,680
+19% +$1.48K ﹤0.01% 3254
2023
Q3
$7.7K Buy
19,243
+7,500
+64% +$3.7K ﹤0.01% 3238
2023
Q2
$6.38K Sell
11,743
-450
-4% -$289 ﹤0.01% 3218
2023
Q1
$10.4K Hold
12,193
﹤0.01% 3221
2022
Q4
$15.9K Sell
12,193
-2,289
-16% -$3.57K ﹤0.01% 3165
2022
Q3
$26K Buy
14,482
+1,180
+9% +$2.94K ﹤0.01% 3147
2022
Q2
$30K Sell
13,302
-1,045
-7% -$2.5K ﹤0.01% 3129
2022
Q1
$47K Buy
+14,347
New +$50.4K ﹤0.01% 3197
2018
Q4
Sell
-683
Closed -$22K 2749
2018
Q3
$22K Buy
+683
New +$79.1K ﹤0.01% 2760

Other funds holding OCGN

Raymond James Financial Services Advisors's OCGN Position: Q1 2024 in Review

Raymond James Financial Services Advisors sold out of Ocugen (OCGN) in Q1 2024, closing a stake of 22,923 shares — an estimated $13.2K sold.

Raymond James Financial Services Advisors first reported a position in OCGN in Q3 2018 and held it in 9 quarters. The position peaked at $47K in Q1 2022. 81 funds tracked by Wall St. Rank hold OCGN as of Q1 2024.

  • Raymond James Financial Services Advisors reported no remaining Ocugen position as of Q1 2024 after selling out during the quarter.
  • Raymond James Financial Services Advisors sold 22,923 Ocugen shares in Q1 2024, an estimated $13.2K.
  • Raymond James Financial Services Advisors first reported a position in Ocugen in Q3 2018 and held it in 9 quarters.
  • Raymond James Financial Services Advisors's Ocugen position peaked at $47K in Q1 2022.
  • 81 funds tracked by Wall St. Rank held Ocugen as of Q1 2024.

Based on Raymond James Financial Services Advisors's 13F filing for Q1 2024, filed 22 Apr 2024.